QYUNS-B (02509) repurchased a total of 549,800 shares in the past three trading days.

date
22:00 10/11/2025
avatar
GMT Eight
China BioPharmaceuticals Holdings, Inc. (02509) announced that the board of directors believes that the current stock price significantly undervalues the company's worth. With its...
QYUNS-B(02509) announced that the Board of Directors believes that the current stock price severely undervalues the company. With full confidence in the company's future prospects and a high level of recognition of its intrinsic value, in order to continuously enhance market confidence in the company and increase its investment value, the company has repurchased a total of 549,800 ordinary shares as treasury stock from June 20, 2025 to the date of this announcement on the Hong Kong Stock Exchange according to the share repurchase authorization approved by the company's shareholders at the annual general meeting held on June 20, 2025. The repurchased shares account for approximately 0.24% of the total number of shares issued by the company as of the date of this announcement. The total amount involved in the repurchase as of the date of this announcement is approximately HK$11.07 million (excluding commission and other expenses).